arrow
A

Anna Collén

AstraZeneca
H指数:18
被引数:1,469

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial

米替哌stat抑制髓过氧化物酶在射血分数保留或轻度降低的心力衰竭中的应用:一项随机2b期试验

2026-09-090
PRE
Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trial

抗体介导的LOX-1抑制在心肌梗死后残留炎症患者中的疗效:一项随机第2期临床试验

2025-09-250
PRE
Relationship of Soluble Lectin-Like Low-Density Lipoprotein Receptor-1 (sLOX-1) With Inflammation and Coronary Plaque Progression in Psoriasis
2023-11-212
OAAI
Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease
2023-10-234
OAAI
Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction
2023-08-2217
OA
Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotides
2022-03-0112
OAAI